Details of the Drug

General Information of Drug (ID: DM2JZC8)

Drug Name

PF-4136309

Synonyms

PF-4136309; 1341224-83-6; INCB-8761; INCB 8761; INCB8761; 857679-55-1; INCB8761(PF-4136309); PF4136309; PF 4136309; CHEMBL2029422; N-[2-[(3S)-3-[[4-hydroxy-4-(5-pyrimidin-2-ylpyridin-2-yl)cyclohexyl]amino]pyrrolidin-1-yl]-2-oxoethyl]-3-(trifluoromethyl)benzamide; N-[2-((3S)-3-{[4-Hydroxy-4-(5-pyrimidin-2-ylpyridin-2-yl)cyclohexyl]amino}pyrrolidin-1-yl)-2-oxoethyl]-3-(trifluoromethyl)benzamide; INCB8761 PF-4136309; INCB8761/PF-4136309; SCHEMBL1377713; GTPL9032; ZNSVOHSYDRPBGI-CBQRAPNFSA-N; MolPort-039-139-774

Indication

Disease Entry	ICD 11	Status	REF
Hepatitis C virus infection	1E51.1	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C29H31F3N6O3
Canonical SMILES: C1CC(CCC1NC2CCN(C2)C(=O)CNC(=O)C3=CC(=CC=C3)C(F)(F)F)(C4=NC=C(C=C4)C5=NC=CC=N5)O
InChI: 1S/C29H31F3N6O3/c30-29(31,32)21-4-1-3-19(15-21)27(40)36-17-25(39)38-14-9-23(18-38)37-22-7-10-28(41,11-8-22)24-6-5-20(16-35-24)26-33-12-2-13-34-26/h1-6,12-13,15-16,22-23,37,41H,7-11,14,17-18H2,(H,36,40)/t22?,23-,28?/m0/s1
InChIKey: ZNSVOHSYDRPBGI-CBQRAPNFSA-N

Cross-matching ID

PubChem CID: 11192346
CAS Number: 1341224-83-6
TTD ID: D06EPO

References

1	ClinicalTrials.gov (NCT01226797) Safety And Efficacy Of Oral PF-4136309 In Patients With Chronic Hepatitis C Infection And Abnormal Liver Enzymes. U.S. National Institutes of Health.